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Background: Type D personality – the combination of negative affectivity (NA) and social inhibition (SI) –
has been associated with depression but little is known about underlying mechanisms. We examined
whether (1) Type D is a vulnerability factor for depression in general, (2) Type D is associated with
inﬂammation or endothelial dysfunction, and (3) these biomarkers alter the possible association be-
tween Type D and depression.
Methods: In the Maastricht Study, 712 subjects underwent assessment of NA, SI and Type D personality
(DS14), depressive disorder (Mini-International Neuropsychiatric Interview) and depressive symptoms
(Patient Health Questionnaire-9). Plasma biomarkers of inﬂammation (hsCRP, SAA, sICAM-1, IL-6, IL-8,
TNF-α) and endothelial dysfunction (sVCAM-1, sICAM-1, E-selectin, vWF) were measured with sandwich
immunoassays or ELISA and combined into standardized sumscores.
Results: Regarding personality, 49% of the study population was low in NA and SI, 22% had SI only, 12%
NA only and 17% had Type D. Depressive disorder and depressive symptoms were signiﬁcantly more
prevalent in Type D versus the other three personality subgroups. Multivariable regression analyses
showed that Type D was associated with inﬂammation (β¼0.228, p¼0.014) and endothelial dysfunction
(β¼0.216, p¼0.022). After adjustment for these biomarkers, Type D remained independently associated
with increased vulnerability to depressive disorder (OR¼13.20, po0.001) and depressive symptoms
(β¼3.87, po0.001).
Limitations: The cross-sectional design restrained us to draw any conclusions on causality. The relatively
low prevalence of depressive disorder restrained us to adjust for more potential confounders.
Conclusions: Type D personality may be a vulnerability factor for depression, irrespective of levels of
inﬂammation or endothelial dysfunction. Future research should examine possible underlying me-
chanisms.
& 2015 Elsevier B.V. All rights reserved.Clinical Psychology, Tilburg
erlands.1. Introduction
Depression is one of the strongest contributors to the global
burden of disease (Mathers and Loncar, 2006), leading to the onset
of a wide range of cardiovascular diseases (Hare et al., 2014), in-
creasing mortality rates (Cuijpers et al., 2014) and reducing quality
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mains to be elucidated but several biological mechanisms have
been proposed to increase the risk for depression such as the
vascular depression hypothesis (Krishnan et al., 1997), systemic
low-grade inﬂammation (Valkanova et al., 2013), endothelial
dysfunction (Cooper et al., 2011) and chronic dysregulations of the
HPA axis (Belvederi Murri et al., 2014). In addition, psychosocial
‘vulnerability’ factors, such as stressful life events (Paykel, 2003),
distorted cognition (Beck, 1991) and Type D (distressed) person-
ality (Pedersen et al., 2006), could also contribute to depression.
The Type D personality construct is characterized by a high
score on two stable personality traits; negative affectivity and
social inhibition (Denollet, 1993; Denollet and De Potter, 1992).
Negative affectivity (NA) refers to the tendency to experience ne-
gative emotions such as anger or anxiety across time and situa-
tions (Watson and Pennebaker, 1989). Social inhibition (SI) is the
tendency to inhibit the expression of emotions and behaviors in
social interactions (Asendorpf, 1993).
Previous research suggests that Type D may predict the onset
(Pedersen et al., 2006) and persistence (Doyle et al., 2011a) of
depressive symptoms in patients with coronary artery disease.
Type D personality has also been found to be related to depression
in the general population (Michal et al., 2011) and in patients with
diabetes (Nefs et al., 2015). It is still unclear why Type D could
represent a vulnerability factor for depression. As previously
mentioned, biological factors such as low-grade inﬂammation and
endothelial dysfunction may induce depression. Various hy-
potheses have been proposed as an explanation for the association
of inﬂammation with depression. First, inﬂammation could in-
duces sickness behavior, which is closely related to or may induce
symptoms of depression. A previous review by Dantzer et al.
(Dantzer et al., 2008) concluded that pro-inﬂammatory cytokines
are able to cause depressive disorder (cytokine theory of depres-
sion), via immune-to-brain communication in which pro-in-
ﬂammatory cytokines cause feelings of depression via different
pathways. Another potential pathway for the association of in-
ﬂammation with depression refers to the kynurenine hypothesis.
This hypothesis postulates that in depression, cortisol-inducible
activation of the liver enzyme, tryptophan 2,3-dioxygenase (TDO),
shunts metabolism of tryptophan away from serotonin production
towards kynurenine production, consequently leading to serotonin
deﬁciency in the brain, and thus contributing to the pathogenesis
of depression (Oxenkrug, 2013).
Type D personality has also been related to increased levels of
inﬂammatory biomarkers (Conraads et al., 2006; Denollet et al.,
2009; Granville Smith et al., 2015) and reduced endothelial func-
tion (Van Craenenbroeck et al., 2009) in patients with cardiovas-
cular disease. Therefore, there is a possibility that low-grade in-
ﬂammation or endothelial dysfunction could (partly) explain the
increased risk of depression associated with Type D personality.
Against this background, the aim of this study was to in-
vestigate (A) whether Type D is a vulnerability factor for depres-
sion in the Maastricht Study (Schram et al., 2014) and (B) whether
Type D is associated with biomarkers of inﬂammation or en-
dothelial dysfunction. In addition, we examined whether the
possible association between Type D and depression is in-
dependent of these biomarkers.Methods
Study population
In this study, we used data from the Maastricht Study, an ob-
servational prospective population-based cohort study. The ratio-
nale and methodology have been described previously (Schramet al., 2014). In brief, the study focuses on the etiology, patho-
physiology, complications and comorbidities of type 2 diabetes
mellitus and is characterized by an extensive phenotyping ap-
proach, including an extensive module on depression and per-
sonality traits. Eligible for participation were all individuals aged
between 40 and 75 years and living in the southern part of the
Netherlands. Participants were recruited through mass media
campaigns and from the municipal registries and the regional
Diabetes Patient Registry via mailings. Recruitment was stratiﬁed
according to known type 2 diabetes status for reasons of efﬁciency.
The present report includes cross-sectional data from the ﬁrst 712
participants, who completed the baseline survey between No-
vember 2010 and March 2012. The examinations of each partici-
pant were performed within a time window of three months. The
study has been approved by the institutional medical ethical
committee (NL31329.068.10) and the Netherlands Health Council
under the Dutch “Law for Population Studies” (Permit 131088-
105234-PG). All participants gave written informed consent.
Assessment of Type D personality
Type D personality was measured with the 14-item Type D
Scale (DS14) (Denollet, 2005). The DS14 comprises fourteen items
that are scored on a ﬁve-point rating scale ranging from 0¼“false”
to 4¼“true”. The scale comprises two subscales, negative affec-
tivity (NA) and social inhibition (SI), containing seven items each.
In the present study, a standard cut-off of 10 is used to identify
individuals who are high on negative affectivity and/or high on
social inhibition (Denollet, 2005). Individuals with a score of Z10
on both subscales are considered to have a Type D personality.
Both subscales have good test–retest validity and high internal
validity with Cronbach’s α of 0.88 and 0.86 for the negative af-
fectivity and social inhibition subscales, respectively (Denollet,
2005). To test the robustness of the Type D model, we classiﬁed all
participants in four personality categories, to compare the sepa-
rate and combined effects of high and low trait levels; low nega-
tive affectivity/ low inhibition (reference group), low negative af-
fectivity/high inhibition (SI only), high negative affectivity/low
inhibition (NA only) and high negative affectivity/high inhibition
(Type D).
The DS14 has been validated in previous research, also in pri-
mary care patients with type 2 diabetes (Nefs et al., 2012) and
healthy controls (Pedersen and Denollet, 2004).
Assessment of depression
Depressive disorder was assessed by the Mini-International
Neuropsychiatric Interview (MINI) (Sheehan et al., 1998). The MINI
is a short diagnostic structured interview, used to assess the pre-
sence of minor and major depressive disorder in the preceding
two weeks according the criteria of the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV). Depressive
symptoms were assessed with a validated Dutch version of the
9-item Patient Health Questionnaire (PHQ-9) (Kroenke et al.,
2001). The PHQ-9 is a self-administered questionnaire based on
the DMS-IV (Association, 1994) criteria for a major depressive
disorder. It comprises nine items rated on a four-point scale, ran-
ging from 0¼“not at all” to 3¼“nearly every day”. Response op-
tions generate a continuous score ranging from 0 (no symptoms)
to 27 (all symptoms present nearly every day). The internal con-
sistency of The PHQ-9 is good, with a Cronbach’s α of 0.88 (Lowe
et al., 2004).
Markers of inﬂammation and endothelial dysfunction
Inﬂammation and endothelial dysfunction were measured by
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(hsCRP), serum amyloid A (SAA), soluble intercellular adhesion
molecule-1 (sICAM-1), interleukin-6 (IL-6), interleukin-8 (IL-8)
and tumor necrosis factor alpha (TNF-α) (inﬂammation), soluble
vascular cell adhesion molecule-1 (sVCAM-1), sICAM-1, E-selectin
and Von Willebrand factor (vWF) (endothelial dysfunction), in
EDTA plasma with commercially available 4-plex sandwich im-
munoassay kits (Meso Scale Discovery (MSD), Rockville, MD, US).
vWf was determined in citrated plasma with sandwich ELISA
(Dako, Glostrup, Denmark) (de Valk-de Roo et al., 1999). Con-
centrations of vWf were expressed as a percentage of vWf de-
tected in pooled citrated plasma of healthy volunteers. For this
study, the intra- and inter-assay coefﬁcients of variation were 3.0%
and 4.7% for hsCRP, 2.6% and 7.5% for SAA, 2.5% and 5.3% for sI-
CAM-1, 7.2% and 12.7% for IL-6, 3.1% and 5.6% for IL-8, and 4.3% and
7.5% for TNF-α, 3.5% and 5.9% for sVCAM-1, 2.5% and 5.3% for sI-
CAM-1, 6.4% and 6.0% for E-selectin, and 3.2% and 5.4% for vWF,
respectively.
General characteristics
Partner status, alcohol consumption, total physical activity per
week and history of cardiovascular disease were assessed by
means of a questionnaire. Smoking behavior was based on self-
report of smoking cigarettes, cigars and/or pipe tobacco, and di-
vided into three categories, i.e. non-smoker, former smoker and
current smoker. Additionally, lifetime smoking was expressed as
pack-years; one pack-year was deﬁned as one packet (¼20 cigar-
ettes) per day, smoked over a course of 1 year. Fasting venous
blood samples were used to assess glucose levels and HbA1c.
Medication use was assessed by interview.
To determine type 2 diabetes status, all participants (except
those who used insulin) underwent a standardized 7-point oral
glucose tolerance test (OGTT) after an overnight fast as previously
described. Individuals without type 1 diabetes and on diabetes
medication were considered to have T2DM as well (Schram et al.,
2014).
Statistical analyses
Baseline characteristics were compared between individuals
with and without Type D personality by use of Independent
Samples T-test, Mann–Whitney U test and Chi-square tests, where
appropriate. All variables with a skewed distribution were log-
transformed before analyses.
To test the robustness of the Type D model and its association
with depression, participants were classiﬁed into one of four
personality subgroups based on their DS14 scores; a reference
group (NA/SI), SI only subgroup (NA/SIþ), NA only subgroup
(NAþ/SI) and Type D personality subgroup (NAþ/SIþ). We
evaluated whether there were differences in depressive disorder
and depressive symptoms across these four personality subgroups
using a one-way analysis of variance (ANOVA) with post hoc
Bonferroni correction for continuous variables and Chi-square
tests for categorical variables.
For reasons of statistical efﬁciency and to reduce the inﬂuence
of the biological variability of each measure, an overall standar-
dised sumscore was determined for both inﬂammation and en-
dothelial dysfunction, according to predeﬁned clusters of con-
ceptually related biomarkers (Heringa et al., 2014). The overall z-
scores were calculated as follows: for each individual biomarker, a
z-score was calculated according to the formula: (individual value/
population mean)/population standard deviation. The resulting
individual biomarker z-scores were then averaged into an overall
standardised sumscore for both inﬂammation and endothelial
dysfunction using the same formula. The inﬂammation sumscoreconsisted of the biomarkers hsCRP, SAA, sICAM-1, IL-6, IL-8 and
TNF-α; the endothelial dysfunction sumscore consisted of the
biomarkers sVCAM-1, sICAM-1, E-selectin and vWF. sICAM-1 was
included in both sumscores, as it is expressed by both monocytes
and the endothelium (Schram and Stehouwer, 2005). To check
whether this inﬂuenced the results, we also calculated the overall
sumscores for inﬂammation and endothelial dysfunction without
sICAM-1.
Multivariable logistic and linear regression analyses were used
to assess the association of Type D personality with depressive
disorder (MINI) and depressive symptoms (PHQ-9), biomarkers of
inﬂammation (individual and sumscore) and endothelial dys-
function (individual and sumscore). Multivariable analyses were
adjusted for age, sex, type 2 diabetes, prior cardiovascular disease,
physical activity, sumscore of inﬂammation and sumscore of en-
dothelial dysfunction. All statistical tests were two-tailed; a P-
value o0.05 was used for all tests to indicate statistical
signiﬁcance.
In posthoc analyses, all items of the PHQ-9 were analyzed
across the four personality subgroups, using ANOVA with post hoc
Bonferonni correction. Explanatory factor analysis with principal
axis factor extraction indicated two latent factors within the PHQ-
9, the ﬁrst factor corresponds with cognitive symptoms of de-
pression (lack of interest, depressed mood, negative feelings about
oneself, concentration problems, psychomotor agitation/retarda-
tion and suicidal ideation), and the second factor represents so-
matic symptoms of depression (sleeping problems, fatigability and
appetite problems) (Krause et al., 2010). Both factors showed a
high internal consistency, with Cronbach’s alpha values of re-
spectively 0.88 and 0.70. All statistical analyses were performed
using SPSS software, version 19 for Windows.Results
Baseline characteristics
Table 1 shows the study population characteristics according to
the presence or absence of Type D personality. The mean age of
the total study population at baseline was 59.3 years and 55% were
men. In total, 17.3% (n¼123) of the participants had Type D per-
sonality. People with Type D had signiﬁcantly higher levels of
HbA1c and fasting glucose, and were more likely to have type
2 diabetes. In addition, they had higher levels of sICAM-1 and
E-selectin. Moreover, people with Type D spent less hours a week
on physical activity, compared to people without Type D.
Type D personality and depression
According to the DS14 scores, 49% (n¼349) of the study po-
pulation were classiﬁed in the reference subgroup (neither NA nor
SI), 22% (n¼153) in the SI-only subgroup, 12% (n¼87) in the NA-
only subgroup and 17% (n¼123) in the Type D subgroup. Of the
123 persons with Type D personality, 22% (n¼27) had a diagnosis
of depressive disorder and a mean score of 5.9 on the PHQ-9. As
depicted in Fig. 1, only 1% of the reference subgroup and the SI-
only subgroup had a diagnosis of depressive disorder, as compared
to 8% of the NA-only subgroup and 22% of the Type D subgroup.
Chi-square tests revealed signiﬁcant differences on depressive
disorder between the Type D subgroup and the NA-only subgroup
(p¼0.008), Type D subgroup and both the SI-only and reference
group (po0.001) (Fig. 1). In addition, the mean scores on the PHQ-
9 were respectively 1.45; 1.95; 4.14 and 5.88 (Fig. 1). ANOVA
analyses revealed signiﬁcant differences on PHQ-9 mean scores
between the Type D subgroup and the NA-only subgroup
(p¼0.001), Type D subgroup and both the SI-only and reference
Table 1
General characteristics of the Maastricht Study participants by Type D personality.
Total population (n¼712) Type D personality p-Value
No (n¼589) Yes (n¼123)
Male sex (n) 55% (391) 56% (332) 48% (59) 0.089#
Age, years 59.378.5 59.578.4 58.378.7 0.139n
Having a partner (n) 86% (612) 88% (512) 81% (100) 0.067#
Type 2 diabetes (n) 27% (193) 25% (149) 36% (44) 0.017#
HbA1c (%) 6.070.8 5.970.7 6.271.0 0.008nn
Fasting glucose level (mmol/L) 6.171.5 6.071.4 6.472.0 0.031nn
Smoking; packyears 13.9720.8 13.4719.2 16.2727.0 0.186n
Never/former/current (%) 32%/53%/15% 32%/53%/15% 32%/52% /16% 0.917#
Alcohol consumption; no/low/high (%) 17%/53%/30% 16%/53%/31% 20%/56%/ 24% 0.115#
Waist circumference (cm) 97.0713.7 96.8713.1 97.8716.0 0.536n
Total physical activity per week (h/week) 14.278.0 14.578.2 12.877.1 0.040n
History of cardiovascular disease (n) 17% (118) 17% (95) 20% (23) 0.402#
Depressive disorder (n) 6% (39) 2% (12) 22% (27) o0.001#
Depressive symptoms 2.673.6 2.072.5 5.975.7 o0.001^
Biomarkers of inﬂammation and endothelial dysfunction
hsCRP (lg/ml) 1.17 (2.2) 1.14 (2.1) 1.39 (2.4) 0.250^
Median (interquartile range)
SAA (lg/ml) 2.74 (3.3) 2.69 (3.2) 3.49 (4.5) 0.249^
Median (interquartile range)
sICAM-1 (ng/ml) 255.2 (62.5) 253.5 (60.3) 263.8 (71.7) 0.097n
IL-6 (pg/ml) 1.40 (1.1) 1.39 (1.1) 1.49 (1.4) 0.278^
Median (interquartile range)
IL-8 (pg/ml) 3.73 (1.7) 3.71 (1.7) 3.96 (1.9) 0.776^
Median (interquartile range)
TNF-α (pg/ml) 2.52 (1.0) 2.50 (1.0) 2.68 (1.2) 0.076^
Median (interquartile range)
sVCAM-1 (ng/ml) 401.7 (98.7) 400.2 (95.1) 408.9 (114.5) 0.435n
E-selectin (ng/ml) 13.2 (7.4) 12.9 (7.1) 14.5 (8.8) 0.066n
vWF (%) 133.4 (46.6) 132.7 (45.3) 136.8 (52.5) 0.424n
Data are presented as mean7standard deviation unless otherwise indicated.
nIndependent Samples T-Test; #¼Chi-square; ^¼Mann Whitney-U, nn¼T-Test, equal variances not assumed.
HbA1c¼glycated hemoglobin, hsCRP¼high sensitivity C-reactive protein, SAA¼serum amyloid A, sICAM-1¼soluble intercellular adhesion molecule-1, IL-6¼ interleukin-6,
IL-8¼ interleukin-8, TNF-α¼tumor necrosis factor alpha, sVCAM-1¼soluble vascular cell adhesion molecule-1, vWF¼Von Willebrand factor.
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As shown in Table 1, people with Type D personality were more
likely to have a depressive disorder and to suffer from depressive
symptoms compared to people without Type D personality.
Type D personality and biomarkers of inﬂammation and endothelial
dysfunction
Table 2 shows the association of Type D with biomarkers of
inﬂammation and endothelial dysfunction. Univariate linear re-
gression analyses indicated that Type D personality was sig-
niﬁcantly associated with the inﬂammation sumscore (β 0.194,
95%-CI 0.00; 0.38, p¼0.044), also after adjustment for age and sex
(β 0.228, 95%-CI 0.05; 0.41, p¼0.014). Univariate linear regression
analyses did not indicate a signiﬁcant association between Type D
and the endothelial dysfunction sumscore. However, after adjust-
ment for age and sex, linear regression analyses showed a sig-
niﬁcant association between Type D and endothelial dysfunction
(β 0.216, 95%-CI 0.03; 0.40, p¼0.022) (Table 2). Excluding s-ICAM-
1 from the overall sumscores for inﬂammation and endothelial
dysfunction did not change the results (data not shown).
Type D personality, depression and biomarkers
As shown in Table 3, Type D was statistically signiﬁcantly as-
sociated with higher levels of depressive disorder (OR 13.67, 95%-
CI 6.69; 27.91, po0.001) and depressive symptoms (β 3.95, 95%-CI
3.30; 4.59, po0.001). After adjustment for age, sex, inﬂammation
and endothelial dysfunction, Type D remained signiﬁcantlyassociated with depressive disorder (OR 13.20, 95%-CI 6.38; 27.33,
po0.001) and depressive symptoms (β 3.87, 95%-CI 3.22; 4.51,
po0.001) (Table 3). Adjustment for biomarkers of inﬂammation
and endothelial dysfunction did not alter the increased vulner-
ability to depression associated with Type D, neither did type
2 diabetes and prior cardiovascular disease, nor did physical
activity.
Post hoc analyses
Type D personality was differentially associated with the nine
items of the PHQ-9 (Table 4). Importantly, the Type D subgroup
had signiﬁcant higher levels of anhedonia (p¼0.005), depressed
mood (p¼0.002), worthlessness (po0.001), concentration pro-
blems (p¼0.006) and suicide ideation (po0.001) compared to the
NA-only subgroup (Table 4). We also explored whether the asso-
ciation between Type D and depressive symptoms was different
for cognitive symptoms versus somatic symptoms, adjusting for
inﬂammation and endothelial dysfunction (online Supplementary
Table). The results of the univariate and multivariable linear re-
gression analyses showed that Type D personality was statistically
signiﬁcantly associated with higher levels of both cognitive de-
pressive symptoms (fully adjusted model: β 2.61, 95%-CI 2.19; 3.03,
po0.001) and somatic depressive symptoms (fully adjusted
model: β 1.25, 95%-CI 0.93; 1.56, po0.001).
Discussion
The ﬁndings of the current study showed that Type D
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Fig. 1. Percentage of depressive disorder and mean depression score across per-
sonality subgroups.
Table 2
Association of Type D personality with individual biomarkers and sumscore of
inﬂammation and endothelial dysfunction.
Dependent variable Type D personality
β 95% CI p-Value
Log hsCRP 0.171 0.02; 0.37 0.086
Log TNF-α 0.143 0.05; 0.33 0.137
Log SAA 0.185 0.01; 0.38 0.062
sICAM-1 0.153 0.03; 0.33 0.097
Log IL-6 0.062 0.14; 0.26 0.541
Log IL-8 0.021 0.17; 0.21 0.834
Inﬂammation sumscore 0.194 0.00; 0.38 0.044
Inﬂammation sumscoren 0.228 0.05; 0.41 0.014
sVCAM-1 0.087 0.11; 0.28 0.377
sICAM-1 0.153 0.03; 0.33 0.097
E-selectine 0.209 0.02; 0.40 0.033
vWF 0.086 0.11; 0.28 0.378
Endothelial dysfunction sumscore 0.171 0.02; 0.36 0.076
Endothelial dysfunction sumscoren 0.216# 0.03; 0.40 0.022
Data are presented as z-scores.
# A standardized β of 0.216 indicates that the endothelial dysfunction sumscore is
0.216SD higher in individuals with Type D personality compared to individuals
without Type D personality.
n Model is adjusted for age, sex.
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tricht Study. Both depressive disorder and depressive symptoms
were signiﬁcantly more prevalent in the Type D subgroup, com-
pared to the NA-only, SI-only and the reference subgroup. Fur-
thermore, when clustering items of the PHQ-9 in cognitive and
somatic symptoms of depression, we found that both weresigniﬁcantly associated with Type D personality. A signiﬁcant as-
sociation of Type D personality with biomarkers of inﬂammation
and endothelial dysfunction was found. However, neither in-
ﬂammation nor endothelial dysfunction altered the association of
Type D personality with depression.
Our results are in line with previous research on Type D per-
sonality and depression. A longitudinal study of Doyle et al.
(2011a) showed that Type D is a vulnerability factor for depression,
independently predicting depression and its trajectory over time,
conﬁrming previous cross-sectional reports (Doyle et al., 2011b).
Also in line with our results are the large effect sizes reported in
studies on the association of Type D with depression in patients
with diabetes (Nefs et al., 2015). In addition, Hausteiner et al.
(2010) demonstrated in a population-based study a 11-fold in-
creased odds of high depressive symptoms for men, and a 7-fold
increased odds for women in people with Type D personality.
In our study, we extend these ﬁndings by looking beyond the
Type D/non-Type D dichotomy to include four different person-
ality groups as a function of high and low NA and SI levels. These
analyses showed that higher levels of depression in persons with
Type D personality cannot be explained by the NA-trait only. De-
pressive disorder and depressive symptoms are established to be
signiﬁcantly more prevalent in participants with Type D person-
ality versus participants with only the NA-trait or the SI-trait, in
the Maastricht Study. In addition, we observed signiﬁcant differ-
ences between the personality subgroups are presented on in-
dividual items of the PHQ-9 questionnaire. All items of the PHQ-9
were signiﬁcantly different for Type D personality group compared
to the SI-only group. Moreover, compared to NA-only subjects, the
Type D subgroup had even higher scores on anhedonia, depressed
mood, worthlessness, concentration problems and suicide idea-
tion, the cognitive–affective symptoms of depression. This sup-
ports the notion that the SI-component, in combination with NA,
further increases the risk of depression. This is also in line with
previous research among people with coronary artery disease
(Bunevicius et al., 2014) showing signiﬁcant differences in cogni-
tive–affective symptoms of depression between Type D subgroup
and NA-only.
Our ﬁnding that Type D personality is associated with in-
ﬂammation is supported by research of Einvik et al. (2011) who
found higher levels of hsCRP in people with Type D personality
compared to those without. Also a recent study of Hur et al. (2014)
showed that Type D personality was independently associated
with signiﬁcant immune activation and increased levels of TNF-α
activity. Our results expand these ﬁndings, by analyzing multiple
inﬂammatory biomarkers and combining them into predeﬁned
clusters of conceptually related biomarkers (Heringa et al., 2014).
Studies on the association of Type D with endothelial dys-
function are scarce. One study reported a reduction of 54% of en-
dothelial progenitor cells in Type D compared with non-Type D
persons (Van Craenenbroeck et al., 2009), however, another study
reported no association of Type D with endothelial dysfunction
(Beutel et al., 2012). To our knowledge, we are the ﬁrst to examine
the association of Type D with endothelial function in a large
population-based study, assessing a wide variety of biomarkers,
and showing a signiﬁcant association.
One potential mechanism through which Type D personality
might exert a negative inﬂuence on depression includes in-
ﬂammation and/or endothelial dysfunction. We examined this
theory, but found no effect of inﬂammation or endothelial dys-
function in our multivariable analyses. Similar ﬁndings were ob-
served in a study of Mommersteeg et al. (2012), who reported that
Type D was signiﬁcantly associated with lower levels of mental
health status and increased levels of inﬂammatory biomarkers in
cardiac patients, whereas these biomarkers did not alter the as-
sociation of Type D with mental health status.
Table 3
Association of Type D personality with depression adjusting for inﬂammation and endothelial dysfunction.
Independent variable Model Depressive disorder (MINI) Depressive symptoms (PHQ-9)
OR 95% CI p-Value β 95% CI p-Value
Type D 1 13.67 6.69; 27.91 o0.001 3.95 3.30; 4.59 o0.001
2 13.83 6.74; 28.38 o0.001 3.88 3.23; 4.52 o0.001
3 13.00 6.30; 26.81 o0.001 3.75 3.11; 4.39 o0.001
4 14.62 6.89; 31.02 o0.001 3.63 2.99; 4.27 o0.001
5 12.93 6.28; 26.61 o0.001 3.88 3.23; 4.52 o0.001
6 13.04 6.32; 26.90 o0.001 3.82 3.18; 4.45 o0.001
7 13.23 6.42; 27.26 o0.001 3.91 3.26; 4.55 o0.001
8 13.20 6.38; 27.33 o0.001 3.87 3.22; 4.51 o0.001
Model 1¼crude.
Model 2¼adjusted for age, sex.
Model 3¼adjusted for age, sex, type 2 diabetes.
Model 4¼adjusted for age, sex, prior cardiovascular disease.
Model 5¼adjusted for age, sex, physical activity.
Model 6¼adjusted for age, sex, sumscore of inﬂammation
Model 7¼adjusted for age, sex, sumscore of endothelial dysfunction
Model 8¼adjusted for age, sex, sumscore of inﬂammation and sumscore of endothelial dysfunction.
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the association of Type D with depression may be explained by
other biological mechanisms. Prolonged disruption of the hy-
pothalamic–pituitary–adrenal (HPA) axis, resulting in high cortisol
levels, have been linked to both Type D and depression (Molloy
et al., 2008; Otte et al., 2004), as well as increased oxidative stress
(Kupper et al., 2009; Smaga et al., 2015). There is also some evi-
dence suggesting that Type D personality may be associated with
depression through behavioral pathways. For example, Type D has
been associated with an unhealthy lifestyle such as physical in-
activity (Hausteiner et al., 2010), which in turn can lead to the
development of depression (Dugan et al., 2015). However, in our
study, physical activity did not alter the increased vulnerability to
depression associated with Type D.
Future studies are needed to explore the possible role of these
mechanisms in the association of Type D with depression. The
Maastricht Study aims to do this in a longitudinal perspective.
Limitations of the current study must be acknowledged. First,
due to the relatively low prevalence of depressive disorder in the
study population (n¼39) we were unable to adjust for more po-
tential confounders, such as socio-economic status. Second, we
examined the association of Type D with depression using a cross-
sectional design, restraining us to draw any conclusions on caus-
ality. Third, we do not have any data on the use of antidepressants
or other antidepressant treatment, which could potentially have
inﬂuenced the results. However, the strengths of our researchTable 4
Mean scores of individual depressive symptoms (PHQ-9) across personality subgroups.
PHQ-9 item Reference group One component of
(n¼349) (n¼153) (n¼
NA /SI NA /SIþ NA
Loss of interest (a) 0.1570.39 0.2170.46 0.5
Depressed mood (b) 0.0570.24 0.0770.31 0.4
Feeling guilty or worthless (f) 0.0570.22 0.0970.28 0.3
Concentration problems (g) 0.1370.36 0.1970.47 0.4
Thoughts about suicide (i) 0.0070.05 0.0170.12 0.11
Insomnia/hypersomnia (c) 0.4770.70 0.6870.81 0.9
Feeling tired or without energy (d) 0.4670.65 0.5470.75 0.8
Change in weight or appetite (e) 0.1070.32 0.1170.41 0.3
Psychomotor agitation/retardation (h) 0.0270.16 0.0370.18 0.2
n NA¼negative affect, SI¼social inhibition.should also be highlighted. We used a wide variety of in-
ﬂammatory and endothelial dysfunction biomarkers, combining
them into an overall z-score which reduces the inﬂuence of the
biological variability of each measure. Furthermore, we used
common and validated measures to assess Type D personality and
depressive symptoms, as well as depressive disorder.
Our study suggests that Type D personality is an important
vulnerability factor for depression, irrespective of biomarkers of
inﬂammation or endothelial dysfunction. Moreover, our research
shows that the combination of NA and SI (Type D) may be parti-
cularly useful to identify individuals who are at increased risk of
depression. Because of the characteristics of Type D personality
(inhibition of expression of emotions and behavior in social in-
teraction) it is less likely that these persons will address their
emotional state during medical visits. Therefore, the DS14 may aid
clinicians in detecting people with Type D personality, who pos-
sibly need special clinical attention, since they are at high risk to
have depression. In addition, it is apparent that persons with Type
D may learn new strategies to reduce their level of distress, for
example by means of behavioral interventions, and in turn reduce
the likelihood of developing depression (Nyklicek et al., 2013).
However, further studies are warranted to examine to which ex-
tent these interventions may alter the risk of depression in people
with Type D personality.Type D Type D personality Type D vs
reference, p
Type D vs
SI only, p
Type D vs
NA only, p
87) (n¼123)
þ /SI NAþ /SIþ
170.67 0.7770.83 o0.001 o0.001 0.005
570.61 0.6870.85 o0.001 o0.001 0.002
070.53 0.5970.89 o0.001 o0.001 o0.001
070.60 0.6570.86 o0.001 o0.001 0.006
70.41 0.3070.72 o0.001 o0.001 o0.001
670.85 1.0170.92 o0.001 0.005 0.999
670.75 1.0870.93 o0.001 o0.001 0.227
570.69 0.4970.81 o0.001 o0.001 0.396
070.58 0.3270.60 o0.001 o0.001 0.128
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